Euroespes S.A.
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neu… Read more
Euroespes S.A. (EEP) - Total Assets
Latest total assets as of December 2022: €11.42 Million EUR
Based on the latest financial reports, Euroespes S.A. (EEP) holds total assets worth €11.42 Million EUR as of December 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Euroespes S.A. - Total Assets Trend (2010–2024)
This chart illustrates how Euroespes S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Euroespes S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Euroespes S.A.'s total assets of €11.42 Million consist of 9.1% current assets and 90.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.1% |
| Accounts Receivable | €116.27K | 1.7% |
| Inventory | €272.08K | 3.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €2.62 Million | 37.7% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how Euroespes S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Euroespes S.A.'s current assets represent 9.1% of total assets in 2024, a decrease from 25.0% in 2010.
- Cash Position: Cash and equivalents constituted 3.1% of total assets in 2024, down from 8.8% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is intangible assets at 37.7% of total assets.
Euroespes S.A. Competitors by Total Assets
Key competitors of Euroespes S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.47 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Euroespes S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Euroespes S.A. generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Euroespes S.A. is currently not profitable relative to its asset base.
Euroespes S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.77 | 1.89 | 0.54 |
| Quick Ratio | 0.59 | 1.52 | 0.24 |
| Cash Ratio | 0.38 | 1.26 | 0.00 |
| Working Capital | €-573.30K | € 1.38 Million | € -970.51K |
Euroespes S.A. - Advanced Valuation Insights
This section examines the relationship between Euroespes S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.88 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | -12.5% |
| Total Assets | €6.94 Million |
| Market Capitalization | $3.02 Million USD |
Valuation Analysis
Below Book Valuation: The market values Euroespes S.A.'s assets below their book value (0.43 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Euroespes S.A.'s assets decreased by 12.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Euroespes S.A. (2010–2024)
The table below shows the annual total assets of Euroespes S.A. from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €6.94 Million | -12.47% |
| 2023-12-31 | €7.93 Million | -30.54% |
| 2022-12-31 | €11.42 Million | -6.79% |
| 2021-12-31 | €12.25 Million | +4.74% |
| 2020-12-31 | €11.70 Million | +2.85% |
| 2019-12-31 | €11.37 Million | -10.87% |
| 2018-12-31 | €12.76 Million | +36.54% |
| 2017-12-31 | €9.35 Million | +5.04% |
| 2016-12-31 | €8.90 Million | +32.17% |
| 2015-12-31 | €6.73 Million | +6.28% |
| 2014-12-31 | €6.33 Million | +23.91% |
| 2010-12-31 | €5.11 Million | -- |